StockComparison Logo
vs

CURE vs SPY

Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and SPDR S&P 500 ETF Trust (SPY, ETF).

5-Year PerformanceSPY has outperformed CURE, delivering a return of +13.3% compared to +2.3%

CURE vs SPY - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Net Assets
CURE
$138M
Winner
SPY
$735B
Expense Ratio
CURE
N/A
SPY
0.09%
Max Drawdown
CURE
69.19%
Winner
SPY
56.47%
Sharpe Ratio
CURE
0.80
Winner
SPY
1.62
5Y Beta
CURE
1.38
Winner
SPY
1.00
P/E Ratio
Winner
CURE
28.04
SPY
28.99
Forward P/E
Winner
CURE
17.34
SPY
22.37
5Y Dividends CAGR
Winner
CURE
63.21%
SPY
5.43%
5Y EPS CAGR
CURE
12.58%
Winner
SPY
26.05%
Debt to Equity
CURE
53.58%
Winner
SPY
32.40%
P/S Ratio
Winner
CURE
1.48
SPY
3.74
P/B Ratio
Winner
CURE
4.58
SPY
5.61

CURE vs SPY - Holdings Comparison

CURE and SPY have 60 common holdings. Overlap is 5.15%

CURE's top 25 holdings weight is 91.92%. SPY's top 25 holdings weight is 52.37%.

RankCURESPY
#1
GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35%
NVIDIA CORP (NVDA) - 8.10%
#2
ELI LILLY AND CO (LLY) - 11.75%
APPLE INC (AAPL) - 7.02%
#3
DREYFUS GOVT CASH MAN INS (n/a) - 10.69%
MICROSOFT CORP (MSFT) - 4.79%
#4
JOHNSON & JOHNSON (JNJ) - 7.72%
AMAZON.COM INC (AMZN) - 4.02%
#5
GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02%
ALPHABET INC CLASS A (GOOGL) - 3.51%
#6
ABBVIE INC (ABBV) - 5.24%
BROADCOM INC (AVGO) - 3.10%
#7
UNITEDHEALTH GROUP INC (UNH) - 4.75%
ALPHABET INC CLASS C (GOOG) - 2.79%
#8
MERCK & CO INC (MRK) - 4.14%
META PLATFORMS INC CLASS A (META) - 2.08%
#9
AMGEN INC (AMGN) - 2.52%
TESLA INC (TSLA) - 1.89%
#10
THERMO FISHER SCIENTIFIC INC (TMO) - 2.34%
MICRON TECHNOLOGY INC (MU) - 1.56%
#11
GILEAD SCIENCES INC (GILD) - 2.31%
BERKSHIRE HATHAWAY INC CLASS B (BRK-B) - 1.37%
#12
INTUITIVE SURGICAL INC (ISRG) - 2.16%
ELI LILLY AND CO (LLY) - 1.31%
#13
ABBOTT LABORATORIES (ABT) - 2.10%
JPMORGAN CHASE & CO (JPM) - 1.28%
#14
PFIZER INC (PFE) - 2.05%
ADVANCED MICRO DEVICES INC (AMD) - 1.27%
#15
BRISTOL-MYERS SQUIBB CO (BMY) - 1.65%
EXXON MOBIL CORP (XOM) - 0.97%
#16
CVS HEALTH CORP (CVS) - 1.61%
INTEL CORP (INTC) - 0.90%
#17
VERTEX PHARMACEUTICALS INC (VRTX) - 1.54%
JOHNSON & JOHNSON (JNJ) - 0.86%
#18
DANAHER CORP (DHR) - 1.51%
VISA INC CLASS A (V) - 0.85%
#19
STRYKER CORP (SYK) - 1.50%
WALMART INC (WMT) - 0.81%
#20
MEDTRONIC PLC (MDT) - 1.38%
CISCO SYSTEMS INC (CSCO) - 0.72%
#21
MCKESSON CORP (MCK) - 1.29%
COSTCO WHOLESALE CORP (COST) - 0.69%
#22
BOSTON SCIENTIFIC CORP (BSX) - 1.19%
CATERPILLAR INC (CAT) - 0.66%
#23
ELEVANCE HEALTH INC (ELV) - 1.19%
MASTERCARD INC CLASS A (MA) - 0.62%
#24
THE CIGNA GROUP (CI) - 1.03%
LAM RESEARCH CORP (LRCX) - 0.62%
#25
REGENERON PHARMACEUTICALS INC (REGN) - 0.89%
ABBVIE INC (ABBV) - 0.58%
Total Holdings65505

CURE vs SPY - Historical Returns

Returns include dividend reinvestment.

1M
Winner
CURE
+14.77%
SPY
+1.90%
3M
CURE
-5.02%
Winner
SPY
+8.55%
6M
CURE
-6.22%
Winner
SPY
+8.18%
1Y
Winner
CURE
+34.45%
SPY
+25.79%
5Y(CAGR)
CURE
+2.34%
Winner
SPY
+13.32%
10Y(CAGR)
CURE
+12.66%
Winner
SPY
+15.19%
Max(CAGR)
Winner
CURE
+23.14%
SPY
+8.47%

CURE vs SPY - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearCURESPY
2026-10.45%+8.26%
2025+22.87%+18.00%
2024-12.90%+25.59%
2023-8.46%+26.72%
2022-17.91%-18.64%
2021+90.55%+30.52%
2020+4.13%+17.28%
2019+62.36%+31.09%
2018-0.75%-5.24%
2017+62.77%+20.78%
2016-12.42%+13.59%
2015+6.24%+1.31%
2014+83.03%+14.56%
2013+153.15%+29.00%
2012+45.79%+14.17%
2011-9.68%+0.85%
2010N/A+13.14%
2009N/A+22.67%
2008N/A-36.25%
2007N/A+5.32%
2006N/A+13.85%
2005N/A+5.32%
2004N/A+10.75%
2003N/A+24.18%
2002N/A-22.42%
2001N/A-10.13%
2000N/A-8.84%
1999N/A+8.61%

CURE vs SPY Drawdown Comparison

The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.

The maximum drawdown for SPY was -55.20%, occurring on Mar 9, 2009. Recovery took 1224 trading sessions.

The current CURE drawdown is -28.04%. The current SPY drawdown is -2.90%.

RankCURESPY
#1-69.19%
Jan 22, 2020 - Jan 6, 2021		-55.20%
Oct 9, 2007 - Aug 16, 2012
#2-52.25%
Apr 8, 2022 - Aug 7, 2025		-47.50%
Mar 24, 2000 - Oct 26, 2006
#3-48.54%
Jul 20, 2015 - Jun 22, 2017		-33.70%
Feb 19, 2020 - Aug 10, 2020
#4-44.44%
Jul 1, 2011 - Mar 15, 2012		-24.50%
Jan 3, 2022 - Dec 13, 2023
#5-42.27%
Oct 1, 2018 - Nov 27, 2019		-19.34%
Sep 20, 2018 - Apr 12, 2019
#6-36.35%
Jan 26, 2018 - Sep 13, 2018		-18.76%
Feb 19, 2025 - Jun 26, 2025
#7-29.28%
Dec 30, 2021 - Apr 8, 2022		-13.02%
Jul 20, 2015 - Apr 18, 2016
#8-22.89%
Aug 17, 2021 - Dec 15, 2021		-10.10%
Jan 26, 2018 - Aug 6, 2018
#9-22.59%
Sep 24, 2014 - Oct 28, 2014		-9.44%
Sep 2, 2020 - Nov 11, 2020
#10-19.78%
Mar 4, 2014 - Jun 19, 2014		-9.30%
Jan 19, 2000 - Mar 17, 2000
#11-19.31%
Oct 17, 2012 - Jan 9, 2013		-9.05%
Jul 19, 2007 - Oct 5, 2007
#12-19.31%
Jan 20, 2021 - Apr 15, 2021		-8.88%
Jan 27, 2026 - Apr 14, 2026
#13-17.38%
Apr 2, 2012 - Jun 29, 2012		-8.41%
Jul 16, 2024 - Sep 19, 2024
#14-15.49%
May 28, 2013 - Jul 12, 2013		-7.35%
Sep 14, 2012 - Jan 2, 2013
#15-14.96%
Dec 8, 2014 - Jan 22, 2015		-7.27%
Sep 18, 2014 - Oct 31, 2014

Correlation

Correlation between CURE and SPY is 0.88 which considered as a strong positive correlation - the stocks tend to move together.

0.88
-101

Dividend Comparison (1999 - 2026)

CURE vs SPY dividend yield comparison.

YearCURESPY
20260.28%0.24%
20251.12%1.07%
20241.17%1.21%
20232.02%1.40%
20220.38%1.65%
20210.02%1.20%
20200.17%1.52%
20190.40%1.75%
20180.70%2.04%
20170.18%1.80%
20160.00%2.03%
20150.00%2.06%
20140.00%1.87%
20131.24%1.81%
20120.03%2.18%
20112.10%2.05%
20100.00%1.80%
20090.00%1.95%
20080.00%3.02%
20070.00%1.85%
20060.00%1.73%
20050.00%1.73%
20040.00%1.82%
20030.00%1.47%
20020.00%1.70%
20010.00%1.25%
20000.00%1.15%
19990.00%0.24%

Select Stocks to Compare

Popular: CURE vs SPY